渤海证券研究所晨会纪要（2026.01.07）-20260107

Fixed Income Research - The core viewpoint indicates a divergence in the issuance guidance rates for credit bonds, with medium to high ratings increasing and low ratings decreasing, resulting in an overall change of -6BP to 4BP [2] - In December, the issuance scale of credit bonds decreased month-on-month, with only short-term financing bonds seeing an increase; net financing for credit bonds decreased while company bonds saw an increase [2] - The secondary market saw an increase in transaction volume for credit bonds in December, with yields showing low volatility; the overall credit spread widened, with most varieties at historical low levels [2] - The report suggests that the supply shortage and strong demand for allocation will continue to drive a recovery in credit bonds, with a long-term downward trend in yields expected [2] - The report emphasizes the importance of adjusting strategies in response to market fluctuations and highlights the need to focus on the trends in interest rate bonds while considering the value of individual bonds [2] Financial Engineering Research - The report notes that all major indices rose, with the margin balance continuing to increase, indicating a recovery in valuations and trading opportunities [4] - For the week of December 24-30, all major A-share indices increased, with the CSI 500 showing the largest rise of 2.79% [5] - The margin balance in the two markets reached 25,472.93 billion yuan, an increase of 236.17 billion yuan from the previous week, with the average daily number of investors participating in margin trading rising by 17.70% [5][6] Industry Research - Pharmaceutical and Biological Industry - The report highlights the ongoing trend in the innovative drug industry, with significant developments in regulatory frameworks and a notable increase in the number of approved innovative drugs [12] - In November, the medical care CPI was 101.6, showing a year-on-year increase of 1.6%, while the pharmaceutical manufacturing PPI was 96.1, down 3.9% year-on-year [12] - The report indicates that the innovative drug industry in China is expected to continue its long-term growth trajectory, with a focus on strategic developments in related sectors [12][13] Industry Research - Metals Industry - The report outlines that the steel industry is expected to continue facing weak demand in January 2026, with prices likely to remain low [16] - For copper, the supply is expected to be sufficient, but high prices may suppress downstream demand, leading to a phase of high price fluctuations [16] - The report suggests that the aluminum industry may see improved profitability due to low prices of alumina and strong demand from sectors like new energy vehicles [18] - The report emphasizes the strategic value of rare earth resources and suggests that the industry is poised for future growth, particularly in new energy and robotics sectors [20]